ALT-803 in combination with anti-CD38 antibody for cancer therapies
- 专利权人:
- Altor Bioscience Corporation
- 发明人:
- Shrestha, Niraj,Liu, Bai,Rhode, Peter,Wong, Hing C.
- 申请号：
- AU2018243550
- 公开号：
- AU2018243550A1
- 申请日:
- 2018.03.30
- 申请国别(地区):
- AU
- 年份:
- 2019
- 代理人:
- 摘要：
- The invention features combination therapies using an IL- 15 -based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ALT-803 COMBINÉ À UN ANTICORPS ANTI-CD38 POUR THÉRAPIES ANTICANCÉREUSES
- ALT-803 COMBINE A UN ANTICORPS ANTI-CD38 POUR THERAPIES ANTICANCEREUSES
- Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
- Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases
- Anti-LAG-3 antibodies and uses thereof
